Healthcare

The telehealth sector, known for its rapid digital innovation, is facing increased regulatory scrutiny. Hims & Hers Health, Inc., a...

Eli Lilly finds itself navigating contrasting fortunes as the pharmaceutical giant simultaneously celebrates a major regulatory victory while confronting an...

The largest health insurer in the United States is charting a course through turbulent waters. UnitedHealth finds itself at a...

Despite facing a recent FDA warning letter and significant stock sales by company executives, shares of telemedicine provider Hims &...

The oncology-focused biotechnology firm Ideaya Biosciences is demonstrating remarkable momentum in the markets. A combination of encouraging clinical trial results...

EssilorLuxottica (ESLX) experienced a significant boost this week, propelled by two major developments: a landmark regulatory approval for a groundbreaking...

The equity chapter for Walgreens Boots Alliance has concluded. The company's shares were delisted from the Nasdaq exchange after its...

Facing a sustained stock decline, healthcare distribution leader Henry Schein is deploying a massive financial tool: a billion-dollar share repurchase...

The equity of health insurer Oscar Health (NYSE: OSCR) is confronting severe headwinds. A combination of significant investor dilution fears,...

The continuous glucose monitoring specialist DexCom finds itself navigating turbulent waters. Despite strong underlying demand for glucose monitoring systems, the...